With regards to the VDRL test
in fluid, it was observed that, when pregnant women did not receive adequate treatment and when concurrent treatment was not provided to their sexual partner, the infants presented reactive VDRL (p = 0.00 and p = 0.04, respectively).
In series of 50 patients with a reactive FTA-ABS and eye findings consistent with ocular syphilis VDRL test
was reactive in only 24% of patients .
At the end of the treatment VDRL test
control was planned.
Patients with a reactive CSF VDRL test
were not more likely than patients with a nonreactive CSF VDRL to report additional neurologic symptoms, have vision loss or bilateral eye involvement, or be diagnosed with severe disease, including retinitis, optic neuritis, or retinal detachment.
The child should be checked for syphilis (VDRL test
) and HIV/AIDS.
When Latent disease: Penicillin VDRL test
is negative, G benzathine, 2.4 million specific treponemal units IM, weekly for 3 antibody tests, such as weeks TPPA and TPFIA, are helpful.
By the non-reactive VDRL test
the possibility of popular eruption of secondary syphilis was ruled out.
Data were collected by all women answered a questionnaire and by investigating blood sample VDRL test
and FTA-ABS test.
Out of total 2488 participants 9 (0.3617%) were found reactive on testing with VDRL test
. All these nine subjects were also found to be positive when tested with TPHA test.